Gray Matter Age Prediction as a Biomarker for Risk of Dementia

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1902376116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

White Matter Disease as a Biomarker for Long-Term Cerebrovascular Disease and Dementia

Current Treatment Options in Cardiovascular Medicine
Cardiovascular MedicineCardiology
2014English

Dynamic Risk Prediction for Diabetes Using Biomarker Change Measurements

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2019English

A Forward Application of Age Associated Gray and White Matter Networks

Human Brain Mapping
Nuclear MedicineRadiologyUltrasound TechnologyAnatomyRadiologicalNeurologyImaging
2008English

Biomarker-Based Risk Prediction in the Community

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2016English

Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification

Diagnostics
Clinical Biochemistry
2018English

Evaluation of Annexin A5 as a Biomarker for Alzheimer's Disease and Dementia With Lewy Bodies

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2013English

Gray and White Matter Water Diffusion in the Syndromic Variants of Frontotemporal Dementia

Neurology
Neurology
2010English

Dementia: A Problem for Our Age

Nature
Multidisciplinary
2011English

Osteocalcin as a Potential Risk Biomarker for Cardiovascular and Metabolic Diseases

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy